Next Article in Journal
Molecular Design of Novel Protein-Degrading Therapeutics Agents Currently in Clinical Trial
Previous Article in Journal
Expanding the Toolbox of Biomedical HIV Prevention Options Through Innovative Design
Previous Article in Special Issue
Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(6), 743; https://doi.org/10.3390/pharmaceutics17060743
Action Date Notes Link
article xml file uploaded 5 June 2025 12:39 CEST Original file -
article xml uploaded. 5 June 2025 12:39 CEST Update https://www.mdpi.com/1999-4923/17/6/743/xml
article pdf uploaded. 5 June 2025 12:39 CEST Version of Record https://www.mdpi.com/1999-4923/17/6/743/pdf
article supplementary file uploaded. 5 June 2025 12:39 CEST - https://www.mdpi.com/1999-4923/17/6/743#supplementary
article html file updated 5 June 2025 12:41 CEST Original file https://www.mdpi.com/1999-4923/17/6/743/html
Back to TopTop